Firstly implantation of the MemoSorb® fully degradable occluder in Northeast China

MemoSorb®- Leading device for congenital heart disease closure.

We are thrilled to share that Professor Yu Bo, the Director of the Cardiovascular Disease Hospital and Chief of Cardiology at the Second Affiliated Hospital of Harbin Medical University, along with Vice Director of Cardiology Dr. Zhang Donghui and their team, have successfully completed the first implantation of the MemoSorb® fully degradable occluder in Northeast China. Under the guidance of Professor Li Fen at the Shanghai Children's Medical Center of Shanghai Jiaotong University School of Medicine, their teamwork and cooperation were critical to the success of this milestone procedure. As an international leading device for congenital heart disease closure, MemoSorb® marks a significant breakthrough from metallic to fully degradable materials, and has attracted attention from clinicians since its launch. The clinical application of this domestically produced occluder is expanding rapidly, and the success of this first implantation in Northeast China confirms its safety and feasibility in atrial septal defect closure.